(PDF) Insights Into the RbMgNH System: An Ordered Mixed

Insights Into the RbMgNH System: An Ordered Mixed Amide/Imide Phase and a Disordered Amide/Hydride Solid Solution

doi 10.1021/acs.inorgchem.7b03232.s001

Full Text

Open PDF

Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs

Frontiers in Endocrinology

English

Trial Design of Phase IIIb, Open-Label, Single Arm Study to Evaluate Efficacy and Safety of Pasireotide LAR in Patients With Inadequately-Controlled Acromegaly Despite Treatment With First-Generation Somatostatin Analogues

Endocrine Abstracts

2015

English

Postoperative Use of Somatostatin Analogs and Mortality in Patients With Acromegaly.

European Journal of Endocrinology

English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

English

Interpreting Biochemical Control Response Rates With First-Generation Somatostatin Analogues in Acromegaly

English

Added Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Response to Somatostatin Analogs in Patients With Acromegaly

English

Progress in the Formulation and Delivery of Somatostatin Analogs for Acromegaly

Therapeutic Delivery

Pharmaceutical Science

2017

English

What Is the Efficacy of Switching to Weekly Pegvisomant in Acromegaly Patients Well Controlled on Combination Therapy?

European Journal of Endocrinology

English

Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in Somatostatin Analogue-Naive Patients With Acromegaly

Journal of Endocrinological Investigation

English

Combined Treatment for Acromegaly With Long-Acting Somatostatin Analogs and Pegvisomant: Long-Term Safety for Up to 4.5 Years (Median 2.2 Years) of Follow-Up in 86 Patients

European Journal of Endocrinology

English

Amanote Research

Insights Into the RbMgNH System: An Ordered Mixed Amide/Imide Phase and a Disordered Amide/Hydride Solid Solution

doi 10.1021/acs.inorgchem.7b03232.s001

Full Text

Abstract

Date

Authors

Publisher

Related search

Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs

Trial Design of Phase IIIb, Open-Label, Single Arm Study to Evaluate Efficacy and Safety of Pasireotide LAR in Patients With Inadequately-Controlled Acromegaly Despite Treatment With First-Generation Somatostatin Analogues

Postoperative Use of Somatostatin Analogs and Mortality in Patients With Acromegaly.

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Interpreting Biochemical Control Response Rates With First-Generation Somatostatin Analogues in Acromegaly

Added Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Response to Somatostatin Analogs in Patients With Acromegaly

Progress in the Formulation and Delivery of Somatostatin Analogs for Acromegaly

What Is the Efficacy of Switching to Weekly Pegvisomant in Acromegaly Patients Well Controlled on Combination Therapy?

Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in Somatostatin Analogue-Naive Patients With Acromegaly

Combined Treatment for Acromegaly With Long-Acting Somatostatin Analogs and Pegvisomant: Long-Term Safety for Up to 4.5 Years (Median 2.2 Years) of Follow-Up in 86 Patients